AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15100562
Drug: Adherents to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adherents to stimulant treatment (n = 41)
Trial: 15100562
Drug: Adherents to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adherents to stimulant treatment (n = 16)
Trial: 15100562
Drug: Medication status
RxNorm normalized name: Statuss Green Reformulated Jan 2012
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication status at year 2
Trial: 15100562
Drug: Adverse effects
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adverse effects of stimulant treatment
Trial: 8512622
Drug: Low-dose ethanol
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low-dose ethanol (LD)
Trial: 8512622
Drug: High-dose ethanol
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-dose ethanol (HD)
Trial: 17121049
Drug: TCM syndrome-typing
RxNorm normalized name: collagen type I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TCM syndrome-typing based therapy (TCM-STBT) combined with cyclosporin
Trial: 12505967
Drug: Torque control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Torque control blocker Univent (Group B)
Trial: 12505967
Drug: Wire-guided Arndt
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wire-guided Arndt blocker (Group C)
Trial: 11276182
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy interventions with visual biofeedback/forceplate training
Trial: 11276182
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy interventions without visual biofeedback/forceplate training (Control)
Trial: 9250745
Drug: Indomethacin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (2 x 50 mg for 7 days)
Trial: 9250745
Drug: Indomethacin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (2 x 50 mg for 14 days)
Trial: 8237989
Drug: Schwarz standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Schwarz standard measles vaccine
Trial: 8237989
Drug: High-titer Edmonston-Zagreb
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-titer Edmonston-Zagreb or Schwarz vaccines
Trial: 29098470
Drug: SBM supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SBM supplement (SBMS) diet (with Lys and Met supplementation)
Trial: 16551966
Drug: Cladribine combined
RxNorm normalized name: Cladribine
DrugBank: Cladribine (DB00242)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cladribine combined with cyclophosphamide (CC)
Trial: 12666705
Drug: Nd:YAG laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nd:YAG laser treatment (100 mj, 20 pps, 2.0 W, 120 seconds)
Trial: 12666705
Drug: CO2 laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CO2 laser treatment (2.0 W, 120 seconds)
Trial: 8694299
Drug: Fenoterol (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol (600 micrograms via metered-dose inhaler, 3 puffs 10 min before induction)
Trial: 8694299
Drug: Placebo (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (3 puffs of aerosol containing no medication)
Trial: 29555457
Drug: NP education
RxNorm normalized name: NP Thyroid Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NP education plus tablet application (interactive conditional logic program)
Trial: 26283035
Drug: Belagenpumatucel-L
RxNorm normalized name: Belagenpumatucel-L (RH 2)
DrugBank: Belagenpumatucel-L (SK-LU-1) (DB17402)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Belagenpumatucel-L
Trial: 23677353
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg of rhBMP-2
Trial: 23677353
Drug: 2.5 mL
RxNorm normalized name: syringe, disposable, 2.5 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mL of autologous bone
Trial: 15828972
Drug: Concurrent distracting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent distracting mental activity (e.g., free-associating on a task-irrelevant theme or listening to music)
Trial: 15828972
Drug: No concurrent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No concurrent distracting mental activity (control condition)
Trial: 1771935
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg roxatidine nocte
Trial: 8150836
Drug: Silver sulfadiazine
RxNorm normalized name: Silver Sulfadiazine
DrugBank: Silver sulfadiazine (DB05245)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silver sulfadiazine cream
Trial: 25828637
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of etoposide
Trial: 21214708
Drug: Ketamine 2.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 2.2 mg kg(‐1) IV
Trial: 21214708
Drug: Alfaxalone 1
RxNorm normalized name: alfaxalone 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfaxalone 1 mg kg(‐1) IV
Trial: 23919898
Drug: Risperidone (3-12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (3-12 mg/day)
Trial: 19553086
Drug: Quetiapine (300-750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine (300-750 mg/day)
Trial: 19553086
Drug: Aripiprazole (12-30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole (12-30 mg/day)
Trial: 15547527
Drug: Metformin (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (1500 mg daily)
Trial: 9213716
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium (17 g MgSO4 in 1000 ml isotonic saline)
Trial: 1909083
Drug: Fluvoxamine (100-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine (100-200 mg daily)
Trial: 1909083
Drug: Mianserin (40-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mianserin (40-80 mg daily)
Trial: 6343041
Drug: Human insulin
RxNorm normalized name: Human insulin
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human insulin (Novo)
Trial: 2870943
Drug: Purified pork
RxNorm normalized name: Insulin purified pork
DrugBank: Insulin pork (DB00071)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Purified pork insulin
Trial: 31574899
Drug: Animal-Assisted Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Animal-Assisted Therapy (AAT) with the presence of a dog during a break (Condition C)
Trial: 30931588
Drug: Lactobacillus reuteri
RxNorm normalized name: Lactobacillus reuteri
DrugBank: Lactobacillus reuteri (DB14224)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus reuteri (2 probiotic tablets 2× per day for 21 days)
Trial: 9878012
Drug: 125 mg
RxNorm normalized name: niacin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125 mg famciclovir
Trial: 25542064
Drug: Placebo (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (125 mg)
Trial: 9878012
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg famciclovir
Trial: 20489689
Drug: Glyceryl trinitrate
RxNorm normalized name: Glyceryl trinitrate
DrugBank: Nitroglycerin (DB00727)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glyceryl trinitrate (GTN) high-dose
Trial: 16680253
Drug: Diclofenac (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac (1 mg x kg(‐1) intramuscular) + remifentanil (0.1 microg x kg(‐1)min(‐1)) + ketamine (0.8 mg x kg(‐1) intravenously)
Trial: 16680253
Drug: Remifentanil (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil (0.1 microg x kg(‐1)min(‐1)) + ketamine (0.8 mg x kg(‐1) intravenously)
Trial: 11523155
Drug: Oral care
RxNorm normalized name: Oral Care Q4 Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral care (tooth brushing after each meal and daily oropharyngeal scrubbing with 1% povidone iodine)
Trial: 11523155
Drug: Professional oral
RxNorm normalized name: Dentek Professional Oral Care Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Professional oral care (provided by dentists or dental hygienists once a week)
Trial: 9020273
Drug: Deltibant (CP-0127)
RxNorm normalized name: CP
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Deltibant (CP-0127) 0.3, 1.0, or 3.0 microg x kg(‐1) x min(‐1) continuous intravenous infusion
Trial: 7942581
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid (AA) 2 g/d
Trial: 2833920
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of nifedipine and lisinopril
Trial: 2833920
Drug: Nifedipine and
RxNorm normalized name: nifedipine and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine and Lisinopril
Trial: 30341961
Drug: Short implants
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short implants (6 mm; GS)
Trial: 30341961
Drug: Long implants
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long implants (11-15 mm; GG)
Trial: 26902851
Drug: all treatment
RxNorm normalized name: UNDECYLENIC ACID 8 g in 30 mL / TOLNAFTATE 1 g in 30 mL TOPICAL LIQUID [Fugal nall treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: all treatment arms
Trial: 24013981
Drug: Comparator treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparator treatments (oral antidiabetic drugs, dietary changes, or other insulins)
Trial: 24013981
Drug: Comparator treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparator treatments
Trial: 24288511
Drug: Treatment (not
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment (not specified in detail)
Trial: 20484612
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral 40-mg dose of laropiprant (LRPT)
Trial: 8820475
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (4.5 g omega‐3 fatty acids/day)
Trial: 20136971
Drug: Endoscopic injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic injection therapy
Trial: 1427365
Drug: Heater probe
RxNorm normalized name: norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Heater probe therapy
Trial: 6994084
Drug: Cimetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 400 mg at bedtime or twice daily for up to 12 months
Trial: 16750703
Drug: Intensive statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive statin therapy (including atorvastatin)
Trial: 14658972
Drug: Mirtazapine (15-45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirtazapine (15-45 mg/day)
Trial: 2106277
Drug: Sodium cromoglycate
RxNorm normalized name: Sodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium cromoglycate hypoosmolar solution (40 mOsmol/L)
Trial: 2106277
Drug: Sodium cromoglycate
RxNorm normalized name: Sodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium cromoglycate isoosmolar solution (288 mOsmol/L)
Trial: 7373088
Drug: Ribavirin (1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ribavirin (1,000 mg/day for five days)
Trial: 27633076
Drug: Neurodevelopmental treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neurodevelopmental treatment (NDT) + Vestibular training (VR)
Trial: 25171666
Drug: Electrical stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrical stimulation treatment in addition to physical therapy (5 days per week for 3 weeks)
Trial: 25171666
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy (hot pack, facial expression exercises, and massage)
Trial: 23176373
Drug: Laser heat
RxNorm normalized name: norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Laser heat therapy (LHT)
Trial: 23176373
Drug: Sham heat
RxNorm normalized name: norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sham heat therapy (SHT)
Trial: 19378542
Drug: Tropisetron (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tropisetron (5 mg)
Trial: 17274493
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment with bisphosphonates and menatetrenone
Trial: 10820872
Drug: Extracorporeal shockwave
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal shockwave therapy (ESWT) with 3 sessions of low energy ESWT (2000 impulses, energy flux density 0.07-0.09 mJ/mm2)
Trial: 1814447
Drug: Conservative local
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative local therapy
Trial: 1814447
Drug: Conservative local
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative local treatment
Trial: 2985353
Drug: Zinc supplement
RxNorm normalized name: Zinc supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplement
Trial: 27022637
Drug: Low-dose subperiosteal
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose subperiosteal anaesthesia (0.9 ml of articaine with 0.5% epinephrine)
Trial: 27022637
Drug: High-dose infiltration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose infiltration anaesthesia (7.2 ml of articaine with 0.5% epinephrine)
Trial: 19384124
Drug: Antenatal betamethasone
RxNorm normalized name: Betamethasone
DrugBank: Betamethasone phosphate (DB14669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antenatal betamethasone (2x12 mg)
Trial: 17442091
Drug: Topical zinc
RxNorm normalized name: bacitracin topical zinc compounding powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical zinc oxide 20% ointment
Trial: 17442091
Drug: Salicylic acid
RxNorm normalized name: Salicylic Acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salicylic acid 15% + lactic acid 15% ointment
Trial: 12536697
Drug: Zafirlukast 20
RxNorm normalized name: zafirlukast 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zafirlukast 20 mg twice daily plus inhaled budelade (half quantity of GINA standard), long-acting aminophyllin 0.2 g twice daily, and inhaled salbutamol when necessary
Trial: 12536697
Drug: Inhaled budelade
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budelade of GINA standard quantity, long-acting aminophyllin 0.2 g twice daily, and inhaled salbutamol when necessary
Trial: 12536697
Drug: Zafirlukast 20
RxNorm normalized name: zafirlukast 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zafirlukast 20 mg twice daily added to standard treatment for stable asthma
Trial: 9430083
Drug: Egg feeding
RxNorm normalized name: EGG
DrugBank: Egg (DB10529)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Egg feeding (two eggs daily)
Trial: 15915304
Drug: Conservative therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative therapies
Trial: 26943113
Drug: Cognitive Orientation
RxNorm normalized name: Oriental melon
DrugBank: Muskmelon (DB15611)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Orientation to Daily Occupational Performance (CO‐OP)
Trial: 30335720
Drug: Low-Carbohydrate Ketogenic
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-Carbohydrate Ketogenic Diet (LCKD) (≤50 g or ≤10% daily intake of carbohydrates)
Trial: 30335720
Drug: Usual Diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual Diet (UD) (>250 g daily intake of carbohydrates)
Trial: 18411010
Drug: Transdermal buprenorphine
RxNorm normalized name: buprenorphine Transdermal System
DrugBank: Buprenorphine (DB00921)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Transdermal buprenorphine 70 microg/h (BUP TDS)
Trial: 15927144
Drug: Behaviour therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behaviour therapy (BT) consisting of self-control procedures offered in six sessions
Trial: 26603250
Drug: Behaviour therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behaviour therapy (BT)
Trial: 8601845
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no amino acid infusion)
Trial: 1981000
Drug: Antacid (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacid (80 ml of suspension; Maalox 70) administered on the evening before dosing and again 2 h before and 2 h after breakfast
Trial: 7012191
Drug: Chlorpheniramine maleate,
RxNorm normalized name: Chlorpheniramine Maleate, 4 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpheniramine maleate, 4 times daily for one week
Trial: 29385005
Drug: 6 hours
RxNorm normalized name: nitroglycerin 0.6 MG/HR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 hours before + immediately before (photobiomodulation therapy [PBMT] applied both 6 hours before and immediately before the test)
Trial: 27745820
Drug: Chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alone (carboplatin and pemetrexed)
Trial: 11843722
Drug: 5 mL
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mL of 0.5% bupivacaine hydrochloride
Trial: 11843722
Drug: 5 mL
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mL of isotonic sodium chloride solution (Control)
Trial: 380614
Drug: Clofibrate (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clofibrate (2 g/day; period B; 2 months)
Trial: 6210878
Drug: Cl2MDP (3200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cl2MDP (3200 mg/day)
Trial: 30690293
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy (doxorubicin plus ifosfamide)
Trial: 17611916
Drug: 3 L
RxNorm normalized name: D3 Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 L of polyethylene glycol solution with a soft diet on the preceding day and then 1 L of the solution on the day of colonoscopy (split-dose)
Trial: 17611916
Drug: 4 L
RxNorm normalized name: PEG-4 laurate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 L of polyethylene glycol solution with a soft diet on the day before colonoscopy (single-dose)
Trial: 16083526
Drug: Ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe 10 mg plus Fluvastatin 20 mg
Trial: 12394229
Drug: Mannitol infusion
RxNorm normalized name: Mannitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mannitol infusion (100‐mL 20% mannitol)
Trial: 12394229
Drug: 5% dextrose
RxNorm normalized name: LMD with 5% Dextrose
DrugBank: D-glucose (DB01914)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% dextrose solution (control group)
Trial: 2310448
Drug: Intraarticular injection
RxNorm normalized name: dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intraarticular injection of bupivacaine (100 mg, 40 mL of 0.25%)
Trial: 2310448
Drug: Intraarticular injection
RxNorm normalized name: dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intraarticular injection of saline
Trial: 2310448
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection of bupivacaine at the portal sites
Trial: 2310448
Drug: Both intraarticular
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both intraarticular and subcutaneous injection of bupivacaine
Trial: 26284906
Drug: C. militaris
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C. militaris (1.5 g/day for 4 weeks)
Trial: 26284906
Drug: Placebo (identical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (identical capsules filled with microcrystalline cellulose and lactose)
Trial: 25451608
Drug: Salmonella typhi
RxNorm normalized name: Salmonella Typhi Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmonella typhi vaccine
Trial: 18223378
Drug: Standard infant
RxNorm normalized name: Standard infant formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard infant formula supplemented with IGF‐1 (10 microg/100 mL of formula)
Trial: 16611656
Drug: Integrated care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated care (IC; n = 65; age mean+/‐sd 70+/‐9 yrs; FEV(1) 1.1+/‐0.5 L, 43% predicted)
Trial: 16611656
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (UC; n = 90; age 72+/‐9 yrs; FEV(1) 1.1+/‐0.05 L, 41% pred)
Trial: 14571611
Drug: Integrative medical
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrative medical treatment (IMT) with serial Chinese recipes and western medicine